BEAT
HeartBeam, Inc.
There isn't enough reported data to score BEAT yet.
BEAT Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Under pressure | |
| Unavailable | |
| Under pressure |
BEAT's profitability and balance sheet are currently under pressure. There isn't enough data to rate its revenue and cash flow.
BEAT PE Valuation
BEAT has no meaningful PE right now: it lost money over the past year.
BEAT Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Decline | |
| -- | |
| Limited | |
| Low |
Analysts expect BEAT's losses to shrink, with revenue declining. However, they disagree widely on these estimates.
BEAT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.41 | +$0.25 |
| Q2 2026 | -$0.51 | +$0.19 |
| Q1 2026 | -$0.56 | +$0.18 |
| Q4 2025 | -$0.62 | +$0.11 |
| Q3 2021 | -$0.51 | -$0.43 |
| Q2 2021 | -$0.23 | -215% |
| Q1 2021 | -$0.14 | -131% |
| Q4 2020 | -$0.16 | -120% |
BEAT is still losing money, but far less than before: $0.41 per share over the past year, against $1.82 at its worst in early 2023.
BEAT Quarterly Revenue
| Quarter | Margin | YoY |
|---|---|---|
| Q4 2019 | 19% | N/A |
BEAT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$2.7M | +$585K |
| Q2 2026 | -$3.6M | -$44K |
| Q1 2026 | -$3.9M | +$621K |
| Q4 2025 | -$3.3M | +$830K |
| Q3 2025 | -$3.2M | +$167K |
| Q2 2025 | -$3.5M | +$13K |
| Q1 2025 | -$4.5M | -$926K |
| Q4 2024 | -$4.2M | -$1.2M |
BEAT has burned cash in almost every quarter: −$13M over the past year, against −$15M the year before.
BEAT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +8.4% | +4.4M shares |
| 1 year | +66% | +22.8M shares |
| 3 years | +596% | +49M shares |
| 5 years | +600% | +49M shares |
| Available history | +55% | +20.3M shares |
BEAT has 57M diluted shares, up 66% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2021 | — |
| Q1 2021 | — |
| Q4 2020 | — |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
| Q4 2019 | — |
BEAT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2020 | 3.8x | Elevated |
| Q2 2020 | 1.8x | Healthy |
| Q1 2020 | 1.8x | Healthy |
| Q4 2019 | 1.4x | Healthy |
BEAT's net debt is about 3.8 years of its operating earnings (EBITDA).
BEAT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.9 | Neutral |
| Stochastic | 16.3 | Oversold |
BEAT's weekly RSI is 38 (neutral) and its Stochastic is 16 (oversold).
BEAT PE vs Healthcare Sector
BEAT has no meaningful PE right now: it lost money over the past year.
BEAT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.43 | 7% below |
| 20 week MA | $0.48 | 17% below |
| 50 week MA | $1.01 | 60% below |
| 100 week MA | $1.35 | 70% below |
| 200 week MA | $1.84 | 78% below |
BEAT is in a downtrend: it's below all five of its weekly moving averages, and 78% below its 200-week average.
BEAT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $4.25 | $3.41 | -20% |
| 2022 | $3.41 | $4.54 | +33% |
| 2023 | $4.54 | $2.35 | -48% |
| 2024 | $2.35 | $2.26 | -3.8% |
| 2025 | $2.26 | $2.44 | +8% |
| 2026 YTD | $2.44 | $0.40 | -84% |
BEAT has finished lower in three of the last five years. It's down 84% so far in 2026.